Constructing healthcare services markets: networks, brokers and the China-England engagement.
Constructing healthcare services markets: networks, brokers and the China-England engagement.
复制标题
DOI：
10.1186/s12992-022-00892-8
复制
发表时间：
2022-12-09
影响因子：
10.8
通讯作者：
Hunter, Benjamin M.
中科院分区：
文献类型：
--
作者：
Salter, Brian;Dong, Yiming;Hunter, Benjamin M.
关键词：
医疗保健服务是一个不断扩大的国际市场，国家医疗保健系统或多或少地参与其中并从中受益。本研究探讨了中英两国在医疗保健服务方面的合作案例，以此作为阐明此类市场关系构建方式的工具。中国和英国对国际医疗服务市场采取不同的做法。与其他领域一样，中国领导层意识到自己与西方领先资本主义国家在医疗保健方面存在知识和技术差距，因此鼓励开展各种国际活动，以弥合这些差距，包括在国际市场上建立新的供需关系。这些参与属于卫生系统发展方法的范围，该方法的基础是建立广泛的政策方向，允许一定程度的地方创新，启动和评估试点研究，并在中央和地方各级颁布新的规划框架。假设新的知识和技术被融入到这一方法中，并在中国专家和领导人的指导下实施。英国的医疗保健系统拥有知识资源，可以提供至少满足部分中国需求的供应，但尚未充分开发出能够实现有效市场反应的手段，尽管这种经济参与得到了英国贸易相关国家部门的支持。因此，中英在患者护理、专业教育以及医院和医疗保健服务发展方面商业关系的发展主要是由具有较高地位的 NHS 信托机构和具有利用其市场地位的创业能力的私营部门组织主导的。这些机构凭借其成熟的国际临床医生和具有国内私营部门提供经验的商业团队，建立了足够强大的基于信任的合作，以促进国际医疗保健服务市场的供需关系。为了使商业交流变得可行和可行，发展关系所需的关键往往是一系列具有技能和能力的国际经纪人，能够为中国的个人医疗保健消费者和机构客户提供必要的联系。远程医疗通信技术是经纪人角色不可或缺的一部分，通常由经纪人本身提供，以实现消费者和医疗保健提供者之间的互动，无论是在患者护理、专业教育还是医疗保健服务开发方面。尽管英国的医疗保健系统具备应对中国市场需求所需的知识，并且这种经济参与得到了英国贸易相关国家部门的支持和积极鼓励，但这种回应受到国内对其资源的多种需求以及NHS医疗保健市场化方法的限制。
Healthcare services is an expanding international market with which national healthcare systems engage, and from which they benefit, to greater and lesser degrees. This study examines the case of the China-England engagement in healthcare services as a vehicle for illuminating the way in which such market relationships are constructed. China and England have different approaches to the international healthcare services market. Aware of the knowledge and technology gaps between itself and the leading capitalist nations of the West in healthcare, as in other sectors, the Chinese leadership has encouraged a variety of international engagements to facilitate the bridging of these gaps including accessing new supply and demand relationships in international markets. These engagements are situated within an approach to health system development based on establishing broad policy directions, allowing a degree of local innovation, initiating and evaluating pilot studies, and promulgating new programmatic frameworks at central and local levels. The assumption is that the new knowledge and technologies are integrated into this approach and implemented under the guidance of Chinese experts and leaders. England’s healthcare system has the knowledge resources to provide the supply to meet at least some of the China demand but has yet to develop fully the means to enable an efficient market response, though such economic engagement is supported by the UK’s trade related departments of state. As a result, the development of China-England commercial relationships in patient care, professional education and hospital and healthcare service development has been led largely by high status NHS Trusts and private sector organisations with the entrepreneurial capacity to exploit their market position. Drawing on their established international clinicians and commercial teams with experience of domestic private sector provision, these institutions have built trust-based collaborations sufficiently robust to facilitate demand-supply relationships in the international healthcare services market. Often key to the development of relations required to make commercial exchange feasible and practicable are a range of international brokers with the skills and capacity to provide the necessary linkage with individual healthcare consumers and institutional clients in China. Integral to the broker role, and often supplied by the broker itself, are the communication technologies of telemedicine to enable the interaction between consumer and healthcare provider, be this in patient care, professional education or healthcare service development. Although England’s healthcare system has the knowledge required to respond to China’s market demand and such economic engagement is supported and actively encouraged by the UK’s trade related departments of state, the response is constrained by multiple domestic demands on its resources and by the limits of the NHS approach to marketisation in healthcare.
登录
查看更多内容
影响因子：
10.8
作者：
Bisht R;Pitchforth E;Murray SF
通讯作者：
Murray SF
影响因子：
12.7
作者：
Connell, John
通讯作者：
Connell, John
影响因子：
2.4
作者：
Connell, John
通讯作者：
Connell, John
影响因子：
2.6
作者：
Aluttis C;Bishaw T;Frank MW
通讯作者：
Frank MW